About

What we do 

About

Our Mission

Phaeno, Inc. has been created to advance original concepts and technology in pursuit of precision medicine.

Phaeno will transform biomedical approaches to a wide range of diseases from Alzheimer’s, Parkinson’s and advanced cancers; to AIDS, Lyme and Covid-19. Our proprietary Precision Sequencing technology has solved a longstanding technical limitation with accurate large scale, full length, single molecule sequencing. This technology can pinpoint the molecules responsible for disease and the drug targets for treatment.

WHO WE ARE 

The Team

William S. Agnew, Ph.D.
Chief Executive Officer
CoInventor, Cofounder

Mark C. Emerick, Ph.D.

Interdisciplinary Sciences
CoInventor, Cofounder

Giovanni  Parmigiani, Ph.D.

Computational Biostatistician
Cofounder

Hedi  Mouchard
Chief Operating Officer
Cofounder

Bill Haack
Chief Business Officer